Wockhardt Hit Again By New U.K. Ban On Key Production Plant
This article was originally published in PharmAsia News
Executive Summary
A second Wockhardt plant in India has led U.K. health authorities to withdraw the company's certificate of good manufacturing practice, essentially barring any of several drugs produced in the plant.